4//SEC Filing
Maricich Yuri 4
Accession 0001062993-21-012387
CIK 0001835567other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 5:23 PM ET
Size
21.4 KB
Accession
0001062993-21-012387
Insider Transaction Report
Form 4
Maricich Yuri
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-03+103,068→ 103,068 totalExercise: $1.09Exp: 2030-03-24→ Common Stock (103,068 underlying) - Award
Class A Common Stock
2021-12-03+73,620→ 73,620 total - Award
Stock Option (Right to Buy)
2021-12-03+44,172→ 44,172 totalExercise: $0.68Exp: 2027-12-13→ Common Stock (44,172 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+103,068→ 103,068 totalExercise: $0.72Exp: 2028-03-21→ Common Stock (103,068 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+73,620→ 73,620 totalExercise: $0.02Exp: 2025-05-05→ Common Stock (73,620 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+176,689→ 176,689 totalExercise: $0.14Exp: 2026-05-10→ Common Stock (176,689 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+88,344→ 88,344 totalExercise: $1.08Exp: 2029-03-14→ Common Stock (88,344 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+220,862→ 220,862 totalExercise: $1.29Exp: 2031-01-26→ Common Stock (220,862 underlying)
Footnotes (12)
- [F1]Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for 50,000 shares of common stock of Private Pear previously held by Mr. Maricich.
- [F10]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 70,000 shares of common stock of Private Pear for $1.60 per share.
- [F11]25% of the shares underlying the option vested or shall vest on January 26, 2022 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
- [F12]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 150,000 shares of common stock of Private Pear for $1.89 per share.
- [F2]100% of the shares subject to this option are fully vested and exercisable.
- [F3]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 50,000 shares of common stock of Private Pear for $0.02 per share.
- [F4]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 30,000 shares of common stock of Private Pear for $1.00 per share.
- [F5]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 120,000 shares of common stock of Private Pear for $0.20 per share.
- [F6]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 70,000 shares of common stock of Private Pear for $1.05 per share.
- [F7]25% of the shares underlying the option vested or shall vest on March 14, 2020 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
- [F8]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 60,000 shares of common stock of Private Pear for $1.58 per share.
- [F9]25% of the shares underlying the option vested or shall vest on March 24, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
Issuer
Pear Therapeutics, Inc.
CIK 0001835567
Entity typeother
Related Parties
1- filerCIK 0001881045
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 5:23 PM ET
- Size
- 21.4 KB